Article Information
History
- May 13, 2020.
Article Versions
- Version 1 (April 11, 2020 - 06:12).
- Version 2 (April 18, 2020 - 19:48).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- 1Académie Vétérinaire de France, 34, rue Bréguet, 75011 Paris, France
- 2Académie Nationale de Médecine, 16 rue Bonaparte, 75006 Paris, France
- 3Centre National de la Recherche Scientifique (CNRS), Université Paris-Sud, Université Paris-Saclay UMR 9199, Laboratoire des Maladies Neurodégénératives, 18 Route du Panorama, F-92265 Fontenay-aux-Roses, France
- 4Commissariat à I’Energie Atomique et aux Energies Alternatives (CEA), Institut François Jacob, Molecular Imaging Research Center (MIRCen), 18 Route du Panorama, F-92265 Fontenay-aux-Roses, France
- ↵*Correspondance
Marc Dhenain, MIRCen, UMR CEA-CNRS 9199, 18 Route du Panorama, 92 265 Fontenay-aux-Roses CEDEX, France Tel: +33 1 46 54 81 92; Fax: +33 1 46 54 84 51; email: Marc.Dhenain{at}cea.fr
Posted May 13, 2020.
ESTIMATION OF COVID-19 CASES IN FRANCE AND IN DIFFERENT COUNTRIES: HOMOGENEISATION BASED ON MORTALITY
